vs
Side-by-side financial comparison of FirstCash Holdings, Inc. (FCFS) and Guardant Health, Inc. (GH). Click either name above to swap in a different company.
FirstCash Holdings, Inc. is the larger business by last-quarter revenue ($501.3M vs $281.3M, roughly 1.8× Guardant Health, Inc.). FirstCash Holdings, Inc. runs the higher net margin — 20.8% vs -45.7%, a 66.5% gap on every dollar of revenue. On growth, Guardant Health, Inc. posted the faster year-over-year revenue change (39.4% vs 21.2%). Over the past eight quarters, Guardant Health, Inc.'s revenue compounded faster (29.2% CAGR vs 16.9%).
FirstCash Holdings, Inc. is an American pawnshop company headquartered in Fort Worth, Texas which operates retail pawn stores in the U.S. and Latin America. It is a publicly traded company listed on the Nasdaq stock exchange.
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.
FCFS vs GH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $501.3M | $281.3M |
| Net Profit | $104.2M | $-128.5M |
| Gross Margin | — | 64.6% |
| Operating Margin | 28.5% | -43.0% |
| Net Margin | 20.8% | -45.7% |
| Revenue YoY | 21.2% | 39.4% |
| Net Profit YoY | 24.7% | -15.8% |
| EPS (diluted) | $2.35 | $-1.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $501.3M | $281.3M | ||
| Q3 25 | $411.0M | $265.2M | ||
| Q2 25 | $385.1M | $232.1M | ||
| Q1 25 | $371.1M | $203.5M | ||
| Q4 24 | $413.7M | $201.8M | ||
| Q3 24 | $363.1M | $191.5M | ||
| Q2 24 | $363.5M | $177.2M | ||
| Q1 24 | $366.8M | $168.5M |
| Q4 25 | $104.2M | $-128.5M | ||
| Q3 25 | $82.8M | $-92.7M | ||
| Q2 25 | $59.8M | $-99.9M | ||
| Q1 25 | $83.6M | $-95.2M | ||
| Q4 24 | $83.5M | $-111.0M | ||
| Q3 24 | $64.8M | $-107.8M | ||
| Q2 24 | $49.1M | $-102.6M | ||
| Q1 24 | $61.4M | $-115.0M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | 64.7% | ||
| Q2 25 | — | 65.0% | ||
| Q1 25 | — | 63.3% | ||
| Q4 24 | — | 61.6% | ||
| Q3 24 | — | 61.1% | ||
| Q2 24 | — | 59.1% | ||
| Q1 24 | — | 61.2% |
| Q4 25 | 28.5% | -43.0% | ||
| Q3 25 | 27.4% | -37.3% | ||
| Q2 25 | 21.1% | -45.9% | ||
| Q1 25 | 30.0% | -54.6% | ||
| Q4 24 | 26.5% | -62.4% | ||
| Q3 24 | 23.5% | -61.3% | ||
| Q2 24 | 18.2% | -56.8% | ||
| Q1 24 | 22.3% | -59.2% |
| Q4 25 | 20.8% | -45.7% | ||
| Q3 25 | 20.1% | -35.0% | ||
| Q2 25 | 15.5% | -43.0% | ||
| Q1 25 | 22.5% | -46.8% | ||
| Q4 24 | 20.2% | -55.0% | ||
| Q3 24 | 17.9% | -56.3% | ||
| Q2 24 | 13.5% | -57.9% | ||
| Q1 24 | 16.7% | -68.2% |
| Q4 25 | $2.35 | $-1.01 | ||
| Q3 25 | $1.86 | $-0.74 | ||
| Q2 25 | $1.34 | $-0.80 | ||
| Q1 25 | $1.87 | $-0.77 | ||
| Q4 24 | $1.86 | $-0.90 | ||
| Q3 24 | $1.44 | $-0.88 | ||
| Q2 24 | $1.08 | $-0.84 | ||
| Q1 24 | $1.35 | $-0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $125.2M | $378.2M |
| Total DebtLower is stronger | $2.2B | $1.5B |
| Stockholders' EquityBook value | $2.3B | $-99.3M |
| Total Assets | $5.3B | $2.0B |
| Debt / EquityLower = less leverage | 0.98× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $125.2M | $378.2M | ||
| Q3 25 | $130.2M | $580.0M | ||
| Q2 25 | $101.5M | $629.1M | ||
| Q1 25 | $146.0M | $698.6M | ||
| Q4 24 | $175.1M | $525.5M | ||
| Q3 24 | $106.3M | $585.0M | ||
| Q2 24 | $113.7M | $933.7M | ||
| Q1 24 | $135.1M | $1.0B |
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.1B | ||
| Q2 25 | $1.7B | $1.1B | ||
| Q1 25 | $1.7B | $1.1B | ||
| Q4 24 | $1.7B | $1.1B | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | $2.3B | $-99.3M | ||
| Q3 25 | $2.2B | $-354.5M | ||
| Q2 25 | $2.1B | $-305.5M | ||
| Q1 25 | $2.1B | $-250.8M | ||
| Q4 24 | $2.1B | $-139.6M | ||
| Q3 24 | $2.0B | $-60.1M | ||
| Q2 24 | $2.0B | $-1.6M | ||
| Q1 24 | $2.0B | $68.3M |
| Q4 25 | $5.3B | $2.0B | ||
| Q3 25 | $5.2B | $1.3B | ||
| Q2 25 | $4.5B | $1.3B | ||
| Q1 25 | $4.4B | $1.3B | ||
| Q4 24 | $4.5B | $1.5B | ||
| Q3 24 | $4.4B | $1.5B | ||
| Q2 24 | $4.3B | $1.6B | ||
| Q1 24 | $4.2B | $1.7B |
| Q4 25 | 0.98× | — | ||
| Q3 25 | 1.01× | — | ||
| Q2 25 | 0.79× | — | ||
| Q1 25 | 0.83× | — | ||
| Q4 24 | 0.85× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 0.85× | — | ||
| Q1 24 | 0.75× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $206.6M | $-26.4M |
| Free Cash FlowOCF − Capex | — | $-54.2M |
| FCF MarginFCF / Revenue | — | -19.3% |
| Capex IntensityCapex / Revenue | — | 9.9% |
| Cash ConversionOCF / Net Profit | 1.98× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-233.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $206.6M | $-26.4M | ||
| Q3 25 | $135.8M | $-35.4M | ||
| Q2 25 | $116.9M | $-60.3M | ||
| Q1 25 | $126.6M | $-62.7M | ||
| Q4 24 | $198.1M | $-64.5M | ||
| Q3 24 | $113.1M | $-51.1M | ||
| Q2 24 | $106.2M | $-94.0M | ||
| Q1 24 | $122.5M | $-30.3M |
| Q4 25 | — | $-54.2M | ||
| Q3 25 | — | $-45.8M | ||
| Q2 25 | — | $-65.9M | ||
| Q1 25 | — | $-67.1M | ||
| Q4 24 | — | $-83.4M | ||
| Q3 24 | — | $-55.3M | ||
| Q2 24 | — | $-99.1M | ||
| Q1 24 | — | $-37.2M |
| Q4 25 | — | -19.3% | ||
| Q3 25 | — | -17.3% | ||
| Q2 25 | — | -28.4% | ||
| Q1 25 | — | -33.0% | ||
| Q4 24 | — | -41.3% | ||
| Q3 24 | — | -28.9% | ||
| Q2 24 | — | -55.9% | ||
| Q1 24 | — | -22.1% |
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 3.9% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 9.4% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 2.9% | ||
| Q1 24 | — | 4.1% |
| Q4 25 | 1.98× | — | ||
| Q3 25 | 1.64× | — | ||
| Q2 25 | 1.95× | — | ||
| Q1 25 | 1.51× | — | ||
| Q4 24 | 2.37× | — | ||
| Q3 24 | 1.74× | — | ||
| Q2 24 | 2.16× | — | ||
| Q1 24 | 2.00× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FCFS
| US Pawn Segment | $292.2M | 58% |
| Retail POS Payment Solutions | $209.8M | 42% |
GH
| Oncology | $189.9M | 68% |
| Biopharma Data | $54.0M | 19% |
| Screening | $35.1M | 12% |
| Licensing Other | $2.2M | 1% |
